Skip to main content
Investor Relations Contact Us Careers
Nasdaq: FEMY
News Item

Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at Stanford Medicine

December 15, 2023

Femasys began FemBloc pivotal trial enrollment at Stanford Medicine.

View source →
← Back to Media